EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische Studie

Post‐cycle therapy after short‐term anabolic‐androgenic steroid use: comparative outcomes in recreational bodybuilders

Muhammed Arif İbis iD, Tet Yap iD, Maria Satchi iD, Noman Ghazanfar iD, Murat Can Karaburun iD, Omer Onur Cakir iD, Onder Yaman iD, Fabio Castiglione iD

BJU International · 2026

DOI: 10.1111/bju.70059 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift BJU International, 2026. Verfasst von Muhammed Arif İbis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, King's College Hospital NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Chorionic Gonadotropin, Clomiphene, Anabolic Agents, Androgens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives To evaluate the clinical necessity and optimal pharmacological strategy for post‐cycle therapy (PCT) in recreational anabolic‐androgenic steroid (AAS) users with normal pre‐cycle reproductive profiles. Subjects and Methods This retrospective, dual‐centre cohort study included 79 males who had completed ≤6 months of AAS use and had documented normal pre‐cycle reproductive hormone levels and semen parameters. Participants were managed with no treatment (NT; expectant monitoring), clomiphene citrate (CC) monotherapy (25 mg/day; selective oestrogen receptor modulation to stimulate gonadotrophin release), or CC + human chorionic gonadotrophin (hCG) (25 mg/day CC + hCG 1500 IU subcutaneously three times weekly; rapid androgen repletion and testicular stimulation). In patients with follicle‐stimulating hormone (FSH)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chorionic GonadotropinClomipheneAnabolic AgentsAndrogensWeight LiftingHumansMaleRetrospective StudiesAdultTreatment OutcomeYoung AdultErectile DysfunctionOligospermiaAzoospermiaSpermatogenesis

Stichwörter der Autor:innen

IIEF‐15anabolic‐androgenic steroidsclomiphene citratehormonal recoveryhuman chorionic gonadotrophinpost‐cycle therapytesticular volume

Substanzen

Chorionic GonadotropinClomipheneAnabolic AgentsAndrogens

Autor:innen und Institutionen

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, UK.
  • Department of Urology, Ankara University School of Medicine, Ankara, Turkey.
  • Center for Research on Human Reproduction, Ankara University School of Medicine, Ankara, Turkey.
  • Urology Centre, Guy's Hospital, London, UK.
  • School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
  • Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

ORCID-Profile: Muhammed Arif İbis, Tet Yap, Maria Satchi, Noman Ghazanfar, Murat Can Karaburun, Omer Onur Cakir, Onder Yaman, Fabio Castiglione

Zitieren

APA

İbis, M. A., Yap, T., Satchi, M., Ghazanfar, N., Karaburun, M. C., Cakir, O. O., Yaman, O., & Castiglione, F. (2026). Post‐cycle therapy after short‐term anabolic‐androgenic steroid use: comparative outcomes in recreational bodybuilders. BJU International. https://doi.org/10.1111/bju.70059

Vancouver

İbis MA, Yap T, Satchi M, Ghazanfar N, Karaburun MC, Cakir OO, et al. Post‐cycle therapy after short‐term anabolic‐androgenic steroid use: comparative outcomes in recreational bodybuilders. BJU International. 2026. doi:10.1111/bju.70059

BibTeX
@article{bis2026,
  author = {İbis, Muhammed Arif and Yap, Tet and Satchi, Maria and Ghazanfar, Noman and Karaburun, Murat Can and Cakir, Omer Onur and Yaman, Onder and Castiglione, Fabio},
  title = {Post‐cycle therapy after short‐term anabolic‐androgenic steroid use: comparative outcomes in recreational bodybuilders},
  journal = {BJU International},
  year = {2026},
  doi = {10.1111/bju.70059}
}
Kostenlos starten →